TY - JOUR
T1 - Mutations in WNT1 cause different forms of bone fragility
AU - Janda, Claudia
N1 - Funding Information:
We are grateful to all family members who participated in this study, to Esther Milz for excellent technical assistance, and to Karin Boss for critically reading the manuscript. We want to thank Claus-Eric Ott for help with cDNAs and Boi-Dinh Chung-Ueck for kindly providing expression vectors. This work was supported by German Federal Ministry of Education and Research grants 01GM1211A (E-RARE network CRANIRARE-2), 01GM1109C (national rare disease network Forschungsverbund Ausgewählter Craniofacialer Entwicklungsstörungen) to B.W., and 01EC1006A (Molecular Pathogenesis of Osteoporosis) to U.K. and S.M., by TÜBITAK grant 112S398 (E-RARE network CRANIRARE-2) to H.K., and by National Institute of Child Health and Human Development (National Institutes of Health) Intramural Research Program funding to S.L. and J.C.M. M.S. holds a Doc female forte scholarship from Austria and is a member of the Berlin-Brandenburg School for Regenerative Therapies.
PY - 2013/4/4
Y1 - 2013/4/4
N2 - We report that hypofunctional alleles of WNT1 cause autosomal-recessive osteogenesis imperfecta, a congenital disorder characterized by reduced bone mass and recurrent fractures. In consanguineous families, we identified five homozygous mutations in WNT1: one frameshift mutation, two missense mutations, one splice-site mutation, and one nonsense mutation. In addition, in a family affected by dominantly inherited early-onset osteoporosis, a heterozygous WNT1 missense mutation was identified in affected individuals. Initial functional analysis revealed that altered WNT1 proteins fail to activate canonical LRP5-mediated WNT-regulated β-catenin signaling. Furthermore, osteoblasts cultured in vitro showed enhanced Wnt1 expression with advancing differentiation, indicating a role of WNT1 in osteoblast function and bone development. Our finding that homozygous and heterozygous variants in WNT1 predispose to low-bone-mass phenotypes might advance the development of more effective therapeutic strategies for congenital forms of bone fragility, as well as for common forms of age-related osteoporosis.
AB - We report that hypofunctional alleles of WNT1 cause autosomal-recessive osteogenesis imperfecta, a congenital disorder characterized by reduced bone mass and recurrent fractures. In consanguineous families, we identified five homozygous mutations in WNT1: one frameshift mutation, two missense mutations, one splice-site mutation, and one nonsense mutation. In addition, in a family affected by dominantly inherited early-onset osteoporosis, a heterozygous WNT1 missense mutation was identified in affected individuals. Initial functional analysis revealed that altered WNT1 proteins fail to activate canonical LRP5-mediated WNT-regulated β-catenin signaling. Furthermore, osteoblasts cultured in vitro showed enhanced Wnt1 expression with advancing differentiation, indicating a role of WNT1 in osteoblast function and bone development. Our finding that homozygous and heterozygous variants in WNT1 predispose to low-bone-mass phenotypes might advance the development of more effective therapeutic strategies for congenital forms of bone fragility, as well as for common forms of age-related osteoporosis.
UR - https://www.cell.com/ajhg/fulltext/S0002-9297(13)00082-7
U2 - 10.1016/j.ajhg.2013.02.010
DO - 10.1016/j.ajhg.2013.02.010
M3 - Article
SN - 0002-9297
VL - 92
SP - 565
EP - 574
JO - American journal of human genetics
JF - American journal of human genetics
IS - 4
ER -